Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
national blog main
startups
5
×
boston blog main
deals
ipo
new york blog main
san francisco blog main
cancer
clinical trials
fda
national top stories
new york top stories
san diego blog main
san diego top stories
san francisco top stories
venture capital
biogen
boston top stories
boulder/denver blog main
boulder/denver top stories
covid-19
deerfield management
detroit blog main
detroit top stories
drug development
europe blog main
europe top stories
gilead sciences
indiana blog main
indiana top stories
investing
laura shawver
medical device
melinta therapeutics
national
novartis
oric pharmaceuticals
raleigh-durham blog main
What
ipo
5
×
public
bio
biotech
company
covid
developing
markets
medicines
new
plans
roundup
way
acquisitions
activity
advance
announced
approvals
biogen
biology
boost
ceo
clamped
collabs
companies
cytokine
daniel
deal
debut
delays
drugs
economic
enhanced
fast
fda
files
followed
genomics
gilead
gilead’s
Language
unset
Current search:
ipo
×
startups
×
@xconomy.com
3 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
SpringWorks and Satsuma Boost This Week’s Biotech IPO Haul to $595M
@xconomy.com
5 years ago
Synthorx Files for IPO to Advance Enhanced Cytokine Drugs
